Grant: Project Grant
Ottawa Hospital Research Institute
$937,126.00
Role for defective enhancer commissioning in the hypotonia phenotype of Kabuki Syndrome patients
FY 2021-22
Summary
This research project that uses genetic mouse models of the epigenetic enzymes MLL4 and UTX to determine how mutations in these genes give rise to muscle weakness (hypotonia) in children with Kabuki Syndrome. We have characterized mice with mutations in each of these proteins, and found that the muscle stem cells responsible for building and repairing the muscle are very inefficient at generating new muscle fibres. We are exploiting these mouse systems to identify the mechanisms disrupted in these stem cells that prevent efficient repair of the muscle. Thus, the knowledge gained from these studies will be important to the development of new therapies to treat hypotonia in Kabuki Syndrome. Furthermore, as Kabuki Syndrome is a multi-system disease that remains poorly understood for all affected tissues, our strong muscle phenotype observed in mutant mice will allow us to provide the first insight into the disease mechanism with the hope it will help understand the disease progression in other tissues.
Department
Program
Project Grant
Recipient
Location
Ontario, Canada
Recipient Type
Other
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
461314
Name
Dilworth Jeffrey J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Genetics
Projecttitle
Role for defective enhancer commissioning in the hypotonia phenotype of Kabuki Syndrome patients
Programtype2
Operating Grants
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$937,126
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cut&Tag; Enzymatic Function; Epigenetics; Histology; Histone Modifications; Muscle Regeneration; Myofibers; Rna-Sequencing; Stem Cells
Abstract
This research project that uses genetic mouse models of the epigenetic enzymes MLL4 and UTX to determine how mutations in these genes give rise to muscle weakness (hypotonia) in children with Kabuki Syndrome. We have characterized mice with mutations in each of these proteins, and found that the muscle stem cells responsible for building and repairing the muscle are very inefficient at generating new muscle fibres. We are exploiting these mouse systems to identify the mechanisms disrupted in these stem cells that prevent efficient repair of the muscle. Thus, the knowledge gained from these studies will be important to the development of new therapies to treat hypotonia in Kabuki Syndrome. Furthermore, as Kabuki Syndrome is a multi-system disease that remains poorly understood for all affected tissues, our strong muscle phenotype observed in mutant mice will allow us to provide the first insight into the disease mechanism with the hope it will help understand the disease progression in other tissues.
Competitiondate
202203
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Dilworth, Jeffrey J
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $937,126~ $0~